Dosage Forms

Aug 07, 2018
Pharmaceutical companies are developing new strategies to address the ever-increasing development costs for new drug therapies and maximize the value of their existing drug portfolio.
Aug 02, 2018
Pharmaceutical Technology
Increasing dwell time can improve tablet production.
Aug 02, 2018
Pharmaceutical Technology
Low-temperature chemistry enables performance of more challenging and selective chemistry.
Aug 02, 2018
Pharmaceutical Technology
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
Aug 02, 2018
Pharmaceutical Technology
Jean-Yves Balfin, product manager at Korsch AG, speaks to Pharmaceutical Technology about the ins and outs of multilayer tableting.
Aug 02, 2018
Pharmaceutical Technology
This article describes the approaches used during the development of a dexlansoprazole delayed-release orally disintegrating tablet (ODT) to evaluate tablet size and texture as they relate to disintegration rate and patient experience; in addition, the resistance to alcohol was also characterized.
Aug 01, 2018
Pharmaceutical Technology
Determining how much containment is needed for API handling requires evaluation of multiple factors.
Jul 23, 2018
By Pharmaceutical Technology Editors
The acquisition will place Cambrex into the finished dosage form CDMO market.
Jul 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
Jul 09, 2018
By Pharmaceutical Technology Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
native1_300x100
lorem ipsum